APNHY Stock - Aspen Pharmacare Holdings Limited
Unlock GoAI Insights for APNHY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $43.36B | $44.71B | $40.71B | $38.61B | $37.77B |
| Gross Profit | $19.13B | $19.42B | $18.41B | $18.31B | $17.79B |
| Gross Margin | 44.1% | 43.4% | 45.2% | 47.4% | 47.1% |
| Operating Income | $1.44B | $7.00B | $7.82B | $8.67B | $7.07B |
| Net Income | $-1,083,000,000 | $4.40B | $5.23B | $6.49B | $4.81B |
| Net Margin | -2.5% | 9.9% | 12.8% | 16.8% | 12.7% |
| EPS | $-2.44 | $9.91 | $11.77 | $14.32 | $10.53 |
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
Visit WebsiteEarnings History & Surprises
APNHYEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 2, 2026 | — | — | — | — |
Q3 2025 | Sep 3, 2025 | — | $-0.44 | — | — |
Q1 2025 | Mar 3, 2025 | — | $0.35 | — | — |
Q3 2024 | Sep 3, 2024 | $0.57 | $0.26 | -54.4% | ✗ MISS |
Q1 2024 | Mar 14, 2024 | — | $0.28 | — | — |
Q2 2023 | Jun 30, 2023 | $0.48 | $0.31 | -35.7% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | — | $0.36 | — | — |
Q2 2022 | Jun 30, 2022 | $0.48 | $0.42 | -11.0% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $0.46 | — | — |
Q2 2021 | Jun 30, 2021 | $0.38 | $0.19 | -49.9% | ✗ MISS |
Q4 2020 | Dec 31, 2020 | — | $0.34 | — | — |
Q2 2020 | Jun 30, 2020 | $0.45 | $0.28 | -38.2% | ✗ MISS |
Q4 2019 | Dec 31, 2019 | — | $0.41 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.13 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.40 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.35 | — | — |
Q4 2017 | Dec 31, 2017 | — | $0.59 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.39 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.44 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.13 | — | — |
Latest News
Frequently Asked Questions about APNHY
What is APNHY's current stock price?
What is the analyst price target for APNHY?
What sector is Aspen Pharmacare Holdings Limited in?
What is APNHY's market cap?
Does APNHY pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to APNHY for comparison